GPT and Hepatic fibrosis: In recent years, scoring systems based on the joint development of several serological indicators have been proposed, including the aspartate aminotransferase-to-alanine aminotransferase ratio (AST/ALT) (14), the Forns Index (15), the fibrosis-4 index (FIB-4) (16), BARD score (17), and aspartate aminotransferase-to-platelet ratio index (APRI) (18), which are widely used to assess the progression of liver fibrosis, where the required indicators can be calculated from clinical features and routine biochemical tests.